Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.40 |
| ▸ | F7 | P08709 | 3/20 | 0.40 |
| ▸ | F3 | P13726 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | RXRA | P19793 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146047 | 1.00 | ALDH1A1 (0.40) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL22553015 | 0.94 | ALDH1A1 (0.42) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL22553014 | 0.94 | ALDH1A1 (0.42) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL19974257 | 0.93 | ALDH1A1 (0.50) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL19974261 | 0.93 | ALDH1A1 (0.50) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL25178919 | 0.92 | ALDH1A1 (0.45) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL21694495 | 0.92 | ALDH1A1 (0.45) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL21694497 | 0.92 | ALDH1A1 (0.45) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL25185245 | 0.92 | ALDH1A1 (0.45) | ALDH1A1CYP19A1F7F3PPARG | |
| SCHEMBL25178026 | 0.92 | ALDH1A1 (0.45) | ALDH1A1CYP19A1F7F3PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230042328-A1 | IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS | BASF SE (DE) | 2023-02-09 | — | — | US | disclosed |
| WO-2021122673-A1 | IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS | BASF SE (DE) | 2021-06-24 | — | — | WO | disclosed |
| EP-3134380-B1 | METHOD FOR PRODUCING CARBOXYLIC ACID ESTERS IN THE PRESENCE OF AN IONIC LIQUID AND AN ACIDIC ESTERIFICATION CATALYST AND THE USE THEREOF AS PLASTICIZER | BASF SE (DE) | 2019-08-14 | — | — | EP | disclosed |
| US-9776949-B2 | Process for the production of carboxylic esters and use of these as plasticizers | BASF SE (DE) | 2017-10-03 | — | — | US | disclosed |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170044085-A1 | PROCESS FOR THE PRODUCTION OF CARBOXYLIC ESTERS AND USE OF THESE AS PLASTICIZERS | BASF SE (DE) | 2017-02-16 | — | — | US | disclosed |
| EP-2074255-B1 | IONIC LIQUIDS FOR SOLUBILIZING POLYMERS | BASF SE (DE) | 2016-12-14 | — | — | EP | disclosed |
| US-9512354-B2 | Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics | BASF SE (DE) | 2016-12-06 | — | — | US | disclosed |
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-9287597-B2 | Ionic liquid containing hydroxamate and N-alkyl sulfamate ions | FLUIDIC, INC. (US) | 2016-03-15 | — | — | US | disclosed |
| WO-2006066818-A2 | 7-AMINO-6-HETARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THE USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006066799-A1 | 7-AMINO-6-HETEROARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINES AND TO THE USE THEREOF FOR COMBATING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-29 | — | — | WO | disclosed |
| EP-1648890-A2 | ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-26 | — | — | EP | disclosed |
| WO-2006034848-A1 | 7-AMINOMETHYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-06 | — | — | WO | disclosed |
| EP-1620436-A1 | HETEROBICYCLIC COMPOUNDS USED AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-01 | — | — | EP | disclosed |
| WO-2006000436-A1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | WO | disclosed |
| WO-2005120233-A1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING HARMFUL FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005080396-A2 | AZOLOPYRIMIDINE COMPOUNDS AND USE THEREOF FOR COMBATING PARASITIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005010000-A2 | ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-03 | — | — | WO | disclosed |
| WO-2004092175-A1 | HETEROBICYCLIC COMPOUNDS USED AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO2B1, SLC43A3 | ALDH1A1 1455/4885CYP19A1 384/4885F7 3333/4885 |
| US-20170044085-A1 | PROCESS FOR THE PRODUCTION OF CARBOXYLIC ESTERS AND USE OF THESE AS PLASTICIZERS | FASN, ELOVL3, ELOVL5 | ALDH1A1 104/4885CYP19A1 437/4885F7 540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.